Epidemiology of Inflammatory Bowel Diseases in Brazil: A Current Overview

Inflammatory Bowel Disease (IBD) , which includes Crohn's disease and ulcerative colitis, are chronic conditions that affect the gastrointestinal tract and have increasingly impacted the Brazilian population. In recent years, the number of cases and hospitalizations related to these diseases has increased significantly, especially in urban areas and among young people. Understanding this situation is crucial to increasing awareness, improving early diagnosis, and ensuring effective treatment that provides a better quality of life for patients. In this article, we will present a current overview of the epidemiology of IBD in Brazil, highlighting important data and the challenges faced by the healthcare system and society.

The most affected regions are the country's urban and industrialized areas, especially large cities like São Paulo and Rio de Janeiro. The concentration of cases in these regions may be related to environmental factors, urban lifestyle, and exposure to agents that influence the immune system, such as pollution and diet.

IBD primarily affects young people between the ages of 15 and 30, the age range in which symptoms typically appear and impact quality of life. Furthermore, prevalence varies between men and women, although both populations are significantly affected. This profile reinforces the importance of special attention to this age group for early diagnosis and treatment.

In addition to the impact on patients' health, IBD generates high costs for the healthcare system, mainly due to complex treatments and expensive biological medications. Another important issue is the loss of productivity at work, caused by sick leave and physical limitations resulting from the disease's symptoms. This poses a challenge to the economy and public health policies.

Several studies indicate that the diagnosis of IBD in Brazil often occurs late, with an average interval of up to one year between the onset of symptoms and confirmation of the disease, especially in regions such as the Northeast . 

This delay is associated with more severe conditions , a greater risk of complications and the need for prolonged hospitalizations, in addition to negatively impacting patients' quality of life.

The rise in Inflammatory Bowel Disease (IBD) in Brazil, especially in urban areas and among young people, requires increased attention from healthcare professionals and the general public. Early diagnosis, appropriate treatment, and multidisciplinary monitoring are essential to improving patients' quality of life and reducing social and economic costs.

If you experience persistent symptoms such as abdominal pain, bloody diarrhea, or unexplained weight loss, see a gastroenterologist.

MAHTA is by your side, offering reliable information and natural products that help you care for your intestinal health in a regenerative way.

Share this content and help spread awareness about Inflammatory Bowel Disease!